Disease modifying anti-rheumatic drugs (DMARDs) are used to treat a range of inflammatory and autoimmune conditions by reducing disease activity and preventing long-term complications. This page provides information on the safe use, monitoring and management of DMARD therapy.
Inflammatory bowel disease (IBD) includes Crohn’s disease and ulcerative colitis, which cause long-term inflammation of the digestive tract. This page provides prescribing guidance, treatment pathways and supporting information for the management of inflammatory bowel disease.
